Palo Alto Investors LP Pyxis Oncology, Inc. Call Options Transaction History
Palo Alto Investors LP
- $501 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PYXS
# of Institutions
80Shares Held
22.1MCall Options Held
138KPut Options Held
30.9K-
Laurion Capital Management LP New York, NY3.63MShares$3.84 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$2.95 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.49MShares$2.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$2.28 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.1MShares$1.17 Million0.07% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $37.2M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...